UBS Group »

Takeda Pharmaceutical shares owned by UBS Group

Quarter-by-quarter ownership of Takeda Pharmaceutical (TAK) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Takeda Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Takeda Pharmaceutical held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Takeda Pharmaceutical by UBS Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $86M 5.9M 14.64
2025-06-30 $62M 4.0M 15.46
2025-03-31 $26M 1.8M 14.87
2024-12-31 $22M 1.7M 13.24
2024-09-30 $1.0M 73k 14.22
2024-06-30 $1.5M 115k 12.94
2024-03-31 $1.3M 96k 13.89
2023-12-31 $900k 63k 14.27
2023-09-30 $795k 51k 15.47
2023-06-30 $3.3M 210k 15.71
2023-03-31 $1.4M 83k 16.48
2022-12-31 $1.8M 116k 15.60
2022-09-30 $1.6M 124k 12.94
2022-06-30 $1.6M 114k 14.04
2022-03-31 $1.5M 106k 14.31
2021-12-31 $16M 1.2M 13.63
2021-09-30 $7.0M 439k 16.00
2021-06-30 $7.1M 420k 16.80
2021-03-31 $7.9M 433k 18.26
2020-12-31 $1.8M 101k 18.19
2020-09-30 $1.5M 83k 17.84
2020-06-30 $1.6M 87k 17.93
2020-03-31 $1.1M 72k 15.19
2019-12-31 $1.4M 71k 19.76
2019-09-30 $1.3M 75k 17.20
2019-06-30 $1.6M 88k 17.69
2019-03-31 $4.6M 225k 20.37
2018-12-31 $171M 10M 16.83